Abstract
Although the possibilities of antidepressive pharmacotherapy are continuously improving, the rate of nonresponders or partial responders is still relatively high. Suicidal behaviour, the most tragic consequence of untreated or unsuccessfully treated depression, commonly develops in the first few weeks of antidepressive treatment before the onset of therapeutic action and is strongly related to certain specific symptoms of depression like anxiety, agitation and insomnia. The present paper reviews the newly discovered and well-documented antidepressive effect of quetiapine in bipolar and unipolar depression with special regards to its early onset of action, and its sleep-improving effects. Both beneficial effects play an important role in the reduction of suicidal risk frequently seen in depressed patients.
| Original language | Hungarian |
|---|---|
| Pages (from-to) | 211-215 |
| Number of pages | 5 |
| Journal | Neuropsychopharmacologia Hungarica |
| Volume | 11 |
| Issue number | 4 |
| Publication status | Published - 2009 |
Fingerprint
ASJC Scopus subject areas
- Neuroscience(all)
- Pharmacology, Toxicology and Pharmaceutics(all)
- Neuropsychology and Physiological Psychology
- Clinical Neurology
Cite this
A quetiapin XR antidepresszív hatása unipoláris major depresszióban : A korai hatáskezdet és az alvásjavító hatás szerepe az öngyilkossá gi kockázat csökkentésében. / Ríhmer, Z.
In: Neuropsychopharmacologia Hungarica, Vol. 11, No. 4, 2009, p. 211-215.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - A quetiapin XR antidepresszív hatása unipoláris major depresszióban
T2 - A korai hatáskezdet és az alvásjavító hatás szerepe az öngyilkossá gi kockázat csökkentésében
AU - Ríhmer, Z.
PY - 2009
Y1 - 2009
N2 - Although the possibilities of antidepressive pharmacotherapy are continuously improving, the rate of nonresponders or partial responders is still relatively high. Suicidal behaviour, the most tragic consequence of untreated or unsuccessfully treated depression, commonly develops in the first few weeks of antidepressive treatment before the onset of therapeutic action and is strongly related to certain specific symptoms of depression like anxiety, agitation and insomnia. The present paper reviews the newly discovered and well-documented antidepressive effect of quetiapine in bipolar and unipolar depression with special regards to its early onset of action, and its sleep-improving effects. Both beneficial effects play an important role in the reduction of suicidal risk frequently seen in depressed patients.
AB - Although the possibilities of antidepressive pharmacotherapy are continuously improving, the rate of nonresponders or partial responders is still relatively high. Suicidal behaviour, the most tragic consequence of untreated or unsuccessfully treated depression, commonly develops in the first few weeks of antidepressive treatment before the onset of therapeutic action and is strongly related to certain specific symptoms of depression like anxiety, agitation and insomnia. The present paper reviews the newly discovered and well-documented antidepressive effect of quetiapine in bipolar and unipolar depression with special regards to its early onset of action, and its sleep-improving effects. Both beneficial effects play an important role in the reduction of suicidal risk frequently seen in depressed patients.
KW - Insomnia
KW - Major depression
KW - Mirtazapine
KW - Side-effects
KW - Suicide
UR - http://www.scopus.com/inward/record.url?scp=77749327467&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77749327467&partnerID=8YFLogxK
M3 - Article
C2 - 20150658
AN - SCOPUS:77749327467
VL - 11
SP - 211
EP - 215
JO - Neuropsychopharmacologia Hungarica
JF - Neuropsychopharmacologia Hungarica
SN - 1419-8711
IS - 4
ER -